Shenzhen Mindray Bio-Medical Electronics had six patents in future of work during Q2 2024. Shenzhen Mindray Bio-Medical Electronics Co Ltd filed a patent for an ESR detection device and method that collects blood samples, detects erythrocyte disaggregation and reaggregation, processes data to determine abnormalities, and provides alarm prompts to reduce clinical risk. Another patent was filed for a sample analysis system and method that includes analysis devices, a scanning component, an image information obtaining component, and a processor to identify sample identifiers, improving the efficiency of sample testing. GlobalData’s report on Shenzhen Mindray Bio-Medical Electronics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Shenzhen Mindray Bio-Medical Electronics had no grants in future of work as a theme in Q2 2024.
Recent Patents
Application: Esr detection device and esr detection method (Patent ID: US20240159640A1)
The patent filed by Shenzhen Mindray Bio-Medical Electronics Co Ltd describes an ESR detection device and method that includes a sample collecting and dispensing module, an ESR detection module, and a data processing module. The device is designed to collect and dispense a blood sample, obtain disaggregation and aggregation optical data during the process, determine sample abnormalities affecting the ESR detection result, and issue an alarm prompt if an abnormality is detected, thereby reducing clinical risk. The method involves collecting a blood sample, disaggregating and reaggregating erythrocytes to obtain optical data, determining sample abnormalities based on the data, and issuing an alarm if necessary. Additionally, the method includes performing blood routine detection on another part of the blood sample to correct the ESR detection result based on the routine detection data.
The ESR detection device and method aim to improve the accuracy and reliability of ESR detection by utilizing optical data obtained during the disaggregation and reaggregation of erythrocytes in a blood sample. By analyzing this data and detecting sample abnormalities that may affect the ESR detection result, the device and method provide a more comprehensive assessment of the blood sample's characteristics. Furthermore, the inclusion of blood routine detection and correction of the ESR detection result based on this data enhances the overall precision of the detection process. Overall, the device and method offer a sophisticated approach to ESR detection, ensuring better clinical outcomes and reducing potential risks associated with inaccurate results.
To know more about GlobalData’s detailed insights on Shenzhen Mindray Bio-Medical Electronics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
